A blood management technology for cell salvage procedures. Part of Haemonetics' market-leading blood management solutions designed to help hospitals optimize the management of blood products and avoid unnecessary transfusions across the care continuum.
Manufactured by
Haemonetics Corporation
United States
Haemonetics' Global Hospital business provides a range of solutions and enabling technologies designed to enhance patient outcomes, improve procedural effectiveness, and advance healthcare standards. These include: TEG® viscoelastic testing technology delivering timely, actionable information about bleeding and thrombotic risk—helping inform decisions across a variety of clinical settings. BloodTrack® and SafeTrace Tx® transfusion management software supporting transfusion safety by integrating traceable workflows, improving efficiency, and promoting continuity of care. Cell Saver® Elite®+ autotransfusion system helping avoid unnecessary allogeneic transfusions while reducing related costs.
© 2026 Suplivia · Home · Browse Products